Cargando…
Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus
Metformin is an antihyperglycemic agent commonly used for the treatment of Type II diabetes mellitus. However, its effects on patients are derived usually from clinical experiments. In this study, a dynamic model of Type II diabetes mellitus with the treatment of metformin is proposed. The Type II d...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102322/ https://www.ncbi.nlm.nih.gov/pubmed/21625374 http://dx.doi.org/10.2174/1874120701105010001 |
_version_ | 1782204366039547904 |
---|---|
author | Sun, Lin Kwok, Ezra Gopaluni, Bhushan Vahidi, Omid |
author_facet | Sun, Lin Kwok, Ezra Gopaluni, Bhushan Vahidi, Omid |
author_sort | Sun, Lin |
collection | PubMed |
description | Metformin is an antihyperglycemic agent commonly used for the treatment of Type II diabetes mellitus. However, its effects on patients are derived usually from clinical experiments. In this study, a dynamic model of Type II diabetes mellitus with the treatment of metformin is proposed. The Type II diabetic model is a modification of an existing compartmental diabetic model. The dynamic simulation of the metformin effect for a Type II diabetic patient is based on the pharmacokinetic and pharmacodynamic relationship with a human body. The corresponding model parameters are estimated by optimization using clinical data from published reports. Then, the effect of metformin in both intravenous and oral administration on a Type II diabetes mellitus model are compared. The combination treatment of insulin infusion plus oral metformin is shown to be superior than the monotherapy with oral metformin only. These results are consistent with the clinical understanding of the use of metformin. For further work, the model can be analyzed for evaluating the treatment of diabetes mellitus with different pharmacological agents. |
format | Text |
id | pubmed-3102322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-31023222011-05-27 Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus Sun, Lin Kwok, Ezra Gopaluni, Bhushan Vahidi, Omid Open Biomed Eng J Article Metformin is an antihyperglycemic agent commonly used for the treatment of Type II diabetes mellitus. However, its effects on patients are derived usually from clinical experiments. In this study, a dynamic model of Type II diabetes mellitus with the treatment of metformin is proposed. The Type II diabetic model is a modification of an existing compartmental diabetic model. The dynamic simulation of the metformin effect for a Type II diabetic patient is based on the pharmacokinetic and pharmacodynamic relationship with a human body. The corresponding model parameters are estimated by optimization using clinical data from published reports. Then, the effect of metformin in both intravenous and oral administration on a Type II diabetes mellitus model are compared. The combination treatment of insulin infusion plus oral metformin is shown to be superior than the monotherapy with oral metformin only. These results are consistent with the clinical understanding of the use of metformin. For further work, the model can be analyzed for evaluating the treatment of diabetes mellitus with different pharmacological agents. Bentham Open 2011-01-19 /pmc/articles/PMC3102322/ /pubmed/21625374 http://dx.doi.org/10.2174/1874120701105010001 Text en © Sun et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Sun, Lin Kwok, Ezra Gopaluni, Bhushan Vahidi, Omid Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus |
title | Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus |
title_full | Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus |
title_fullStr | Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus |
title_full_unstemmed | Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus |
title_short | Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus |
title_sort | pharmacokinetic-pharmacodynamic modeling of metformin for the treatment of type ii diabetes mellitus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102322/ https://www.ncbi.nlm.nih.gov/pubmed/21625374 http://dx.doi.org/10.2174/1874120701105010001 |
work_keys_str_mv | AT sunlin pharmacokineticpharmacodynamicmodelingofmetforminforthetreatmentoftypeiidiabetesmellitus AT kwokezra pharmacokineticpharmacodynamicmodelingofmetforminforthetreatmentoftypeiidiabetesmellitus AT gopalunibhushan pharmacokineticpharmacodynamicmodelingofmetforminforthetreatmentoftypeiidiabetesmellitus AT vahidiomid pharmacokineticpharmacodynamicmodelingofmetforminforthetreatmentoftypeiidiabetesmellitus |